Logistics of large international trials: the good, the bad, and the ugly.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 19104229.
- Also identified by DOI 10.1097/CCM.0b013e3181922c2d.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The pace of development in intensive care medicine seems to be increasing all the time. Nowhere is that more apparent than in the field of clinical trials. Large international multicenter studies are increasingly being used to evaluate new interventions and to provide epidemiologic data. Such studies promise fast results with good generalizability, but the limitations of these trials should not be forgotten in our search for a speedy conclusion. In this article we will discuss the good, the bad, and the potentially ugly side of international clinical trials in intensive care.
Medical subject headings
- Clinical Trials as Topic
- International Cooperation